Critical Limb Ischemia: Wound Blush Is the Most Important Objective

Critical Limb Ischemia: Wound Blush The aim of this study was to find the optimal angiographic endpoint for infrapopliteal interventions to be able to predict wound healing.

 

Evidence shows acceptable patency and successful limb salvage in patients with critical limb ischemia after infrapopliteal intervention. However, the optimal angiographic endpoint remains unclear. Is it enough to restore flow in one vessel or is it necessary to treat them all? And we should also consider the angiosome guided revascularization approach.

 

Several studies have been conducted to try answer the question of optimal infrapopliteal angioplasty enpoint in patients with critical limb ischemia. This is a subanalysis of the prospective multicenter registry OLIVE (Endovascular Treatment for Infrainguinal Vessels in Patients with Critical Limb Ischemia), that included patients with critical limb ischemia and infrainguinal disease.

 

Researchers analyzed 185 limbs with ischemic ulcers classified as Rutherford 5 or 6 undergoing endovascular treatment.

 

The association of final angiographic outcome and ulcer healing was done using the Cox model.

 

Wound healing rate was 73.5%. The probabilities of proper wound healing were significantly higher in patients with wound blush (79.6% vs. 46.5%; p = 0.01). Wound blush was an independent predictor of wound healing.

 

Conclusion

The presence of wound blush after infrapopliteal intervention was associated with wound healing. Wound blush could be a new angiographic predictor of success in patients with critical limb ischemia

 

Editorial Comment

This new concept complements the angiosome guided approach. In fact, successful angiosome revascularization and ulcer flow restoration may most likely produce wound blush. The benefit of this new concept is that it is far easier to assess in the cath lab and a lot easier to remember (compared to the angiosome), since it reminds us of the myocardial blush of primary PCI.

 

Original Title: Wound Blush Obtainment Is the Most Important Angiographic Endpoint for Wound Healing.

Reference: Makoto Utsunomiya et al. JACC Cardiovasc Interv. 2017 Jan 23;10(2):188-194.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...